Summary

Global Tetanus Toxoid Vaccine Market 2022-2026
Technavio has been monitoring the tetanus toxoid vaccine market and it is poised to grow by $ 1.17 bn during 2022-2026, accelerating at a CAGR of 4.3% during the forecast period. Our report on the tetanus toxoid vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by licensing agreements, rising cases of tetanus, diphtheria, and pertussis, and increasing government initiatives regarding vaccination and immunization.
The tetanus toxoid vaccine market analysis includes the age group segment and geographic landscape.
Technavio's tetanus toxoid vaccine market is segmented as below:
By Age Group
• Neonatals
• Adults
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the new product launches as one of the prime reasons driving the tetanus toxoid vaccine market growth during the next few years. Also, increasing number of immunization campaigns and increasing clinical trials will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on tetanus toxoid vaccine market covers the following areas:
• Tetanus toxoid vaccine market sizing
• Tetanus toxoid vaccine market forecast
• Tetanus toxoid vaccine market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tetanus toxoid vaccine market vendors that include Actiza Pharmaceutical Pvt. Ltd., AJ Vaccines AS, Amson Vaccines and Pharma Pvt Ltd., Avalon Pharma Pvt. Ltd., Bharat Biotech Ltd., CSL Ltd., Dano Vaccines and Biologicals Pvt. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Grifols SA, Incepta Vaccine Ltd., Meiji Holdings Co. Ltd., Merck and Co. Inc., Microgen, Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., and Zoetis Inc. Also, the tetanus toxoid vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/tetanus-toxoid-vaccine-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Age Group
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Age Group
o 5.1 Market segments
o Exhibit 24: Chart on Age Group - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Age Group - Market share 2021-2026 (%)
o 5.2 Comparison by Age Group
o Exhibit
26: Chart on Comparison by Age Group
o Exhibit 27: Data Table on Comparison by Age Group
o 5.3 Neonatals - Market size and forecast 2021-2026
o Exhibit 28: Chart on Neonatals - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Neonatals - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Neonatals - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Neonatals - Year-over-year growth 2021-2026 (%)
o 5.4 Adults - Market size and forecast 2021-2026
o Exhibit 32: Chart on Adults - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Adults - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Adults - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Adults - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Age Group
o Exhibit 36: Market opportunity by Age Group ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 France - Market size and forecast 2021-2026
o Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Avalon Pharma Pvt. Ltd.
o Exhibit 85: Avalon Pharma Pvt. Ltd. - Overview
o Exhibit 86: Avalon Pharma Pvt. Ltd. - Product / Service
o Exhibit 87: Avalon Pharma Pvt. Ltd. - Key offerings
o 10.4 Bharat Biotech Ltd.
o Exhibit 88: Bharat Biotech Ltd. - Overview
o Exhibit 89: Bharat Biotech Ltd. - Product / Service
o Exhibit 90: Bharat Biotech Ltd. - Key news
o Exhibit 91: Bharat Biotech Ltd. - Key offerings
o 10.5 Emergent BioSolutions Inc.
o Exhibit 92: Emergent BioSolutions Inc. - Overview
o Exhibit 93: Emergent BioSolutions Inc. - Product / Service
o Exhibit 94: Emergent BioSolutions Inc. - Key news
o Exhibit 95: Emergent BioSolutions Inc. - Key offerings
o 10.6 GlaxoSmithKline Plc
o Exhibit 96: GlaxoSmithKline Plc - Overview
o Exhibit 97: GlaxoSmithKline Plc - Business segments
o Exhibit 98: GlaxoSmithKline Plc - Key news
o Exhibit 99: GlaxoSmithKline Plc - Key offerings
o Exhibit 100: GlaxoSmithKline Plc - Segment focus
o 10.7 Merck and Co. Inc.
o Exhibit 101: Merck and Co. Inc. - Overview
o Exhibit 102: Merck and Co. Inc. - Business segments
o Exhibit 103: Merck and Co. Inc. - Key news
o Exhibit 104: Merck and Co. Inc. - Key offerings
o Exhibit 105: Merck and Co. Inc. - Segment focus
o 10.8 Panacea Biotec Ltd.
o Exhibit 106: Panacea Biotec Ltd. - Overview
o Exhibit 107: Panacea Biotec Ltd. - Product / Service
o Exhibit 108: Panacea Biotec Ltd. - Key offerings
o 10.9 Pfizer Inc.
o Exhibit 109: Pfizer Inc. - Overview
o Exhibit 110: Pfizer Inc. - Product / Service
o Exhibit 111: Pfizer Inc. - Key news
o Exhibit 112: Pfizer Inc. - Key offerings
o 10.10 Sanofi
o Exhibit 113: Sanofi - Overview
o Exhibit 114: Sanofi - Business segments
o Exhibit 115: Sanofi - Key news
o Exhibit 116: Sanofi - Key offerings
o Exhibit 117: Sanofi - Segment focus
o 10.11 Serum Institute of India Pvt. Ltd.
o Exhibit 118: Serum Institute of India Pvt. Ltd. - Overview
o Exhibit 119: Serum Institute of India Pvt. Ltd. - Product / Service
o Exhibit 120: Serum Institute of India Pvt. Ltd. - Key offerings
o 10.12 Shenzhen Kangtai Biological Products Co. Ltd.
o Exhibit 121: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
o Exhibit 122: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
o Exhibit 123: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 124: Inclusions checklist
o Exhibit 125: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 126: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 127: Research methodology
o Exhibit 128: Validation techniques employed for market sizing
o Exhibit 129: Information sources
o 11.5 List of abbreviations
o Exhibit 130: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Age Group - Market share 2021-2026 (%)
Exhibits25: Data Table on Age Group - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Age Group
Exhibits27: Data Table on Comparison by Age Group
Exhibits28: Chart on Neonatals - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Neonatals - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Neonatals - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Neonatals - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Adults - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Adults - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Adults - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Adults - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Age Group ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Avalon Pharma Pvt. Ltd. - Overview
Exhibits86: Avalon Pharma Pvt. Ltd. - Product / Service
Exhibits87: Avalon Pharma Pvt. Ltd. - Key offerings
Exhibits88: Bharat Biotech Ltd. - Overview
Exhibits89: Bharat Biotech Ltd. - Product / Service
Exhibits90: Bharat Biotech Ltd. - Key news
Exhibits91: Bharat Biotech Ltd. - Key offerings
Exhibits92: Emergent BioSolutions Inc. - Overview
Exhibits93: Emergent BioSolutions Inc. - Product / Service
Exhibits94: Emergent BioSolutions Inc. - Key news
Exhibits95: Emergent BioSolutions Inc. - Key offerings
Exhibits96: GlaxoSmithKline Plc - Overview
Exhibits97: GlaxoSmithKline Plc - Business segments
Exhibits98: GlaxoSmithKline Plc - Key news
Exhibits99: GlaxoSmithKline Plc - Key offerings
Exhibits100: GlaxoSmithKline Plc - Segment focus
Exhibits101: Merck and Co. Inc. - Overview
Exhibits102: Merck and Co. Inc. - Business segments
Exhibits103: Merck and Co. Inc. - Key news
Exhibits104: Merck and Co. Inc. - Key offerings
Exhibits105: Merck and Co. Inc. - Segment focus
Exhibits106: Panacea Biotec Ltd. - Overview
Exhibits107: Panacea Biotec Ltd. - Product / Service
Exhibits108: Panacea Biotec Ltd. - Key offerings
Exhibits109: Pfizer Inc. - Overview
Exhibits110: Pfizer Inc. - Product / Service
Exhibits111: Pfizer Inc. - Key news
Exhibits112: Pfizer Inc. - Key offerings
Exhibits113: Sanofi - Overview
Exhibits114: Sanofi - Business segments
Exhibits115: Sanofi - Key news
Exhibits116: Sanofi - Key offerings
Exhibits117: Sanofi - Segment focus
Exhibits118: Serum Institute of India Pvt. Ltd. - Overview
Exhibits119: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits120: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits121: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibits122: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
Exhibits123: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations